Loading…
Altered phosphorylation of GluA1 in the striatum is associated with locomotor sensitization induced by exposure to increasing doses of morphine
Escalation of drug consumption is involved in the transition from drug use to addiction. Our previous study demonstrated that neuronal activation in ventral tegmental area (VTA) and substantia nigra (SN) was associated with behavioral sensitization induced by increasing doses of morphine. Here we so...
Saved in:
Published in: | European journal of pharmacology 2013-02, Vol.702 (1-3), p.294-301 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c395t-e76b6a0a16637a85338c2f021461a403fccd05f7406d4078d03a1c9f7b5fe5213 |
---|---|
cites | cdi_FETCH-LOGICAL-c395t-e76b6a0a16637a85338c2f021461a403fccd05f7406d4078d03a1c9f7b5fe5213 |
container_end_page | 301 |
container_issue | 1-3 |
container_start_page | 294 |
container_title | European journal of pharmacology |
container_volume | 702 |
creator | Ding, Xuekun Liang, Jing Zheng, Xigeng Bai, Yunjing Liu, Zhengkui Li, Yingying Xing, Xiaoli |
description | Escalation of drug consumption is involved in the transition from drug use to addiction. Our previous study demonstrated that neuronal activation in ventral tegmental area (VTA) and substantia nigra (SN) was associated with behavioral sensitization induced by increasing doses of morphine. Here we sought to characterize the molecular mechanism underlying this behavioral sensitization. We compared mitogen-activated protein kinase (MAPK) signaling following pretreatment with either increasing doses or fixed doses of morphine before and after behavioral sensitization. We found phospho-MAPK markedly increased in ventral striatum and decreased in dorsal striatum after either pretreatment group, but no further change after sensitization induced by 10mg/kg morphine challenge. Furthermore, we also evaluated the level of phospho-glutamate receptor 1 at serine 845 (pSer845-GluA1) and 831 (pSer831-GluA1) sites in ventral striatum and dorsal striatum. The results showed a significant increase in pSer845-GluA1/GluA1 ratio in ventral striatum but not dorsal striatum after pretreatment with increasing doses of morphine but not after fixed-dose or saline pretreatment. Importantly, pSer845-GluA1/GluA1 ratio was increased exclusively in dorsal striatum and not ventral striatum following acute morphine challenge specifically paired with increasing-dose pretreatment and not fixed-dose or saline. These findings indicate that behavioral sensitization-induced by chronic pretreatment with increasing doses of morphine might be more closely associated with the dynamic GluA1 activity in the striatum rather than the modulation of MAPK signaling. These findings also indicate that GluA1 phosphorylation may occur independent of MAPK activation. |
doi_str_mv | 10.1016/j.ejphar.2013.01.051 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1837297508</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S001429991300071X</els_id><sourcerecordid>1837297508</sourcerecordid><originalsourceid>FETCH-LOGICAL-c395t-e76b6a0a16637a85338c2f021461a403fccd05f7406d4078d03a1c9f7b5fe5213</originalsourceid><addsrcrecordid>eNqFkc2O1DAQhC0EYmcH3gAhH7kktO38XpBGq2VBWokLnC2P0yEeJXFwO7DDS_DKeJSFIxwsy1ZVV6s-xl4JyAWI6u0px9MymJBLECoHkUMpnrCdaOo2g1rIp2wHIIpMtm17xa6JTgBQtrJ8zq6kUm0lZbVjvw5jxIAdXwZP6YTzaKLzM_c9vxvXg-Bu5nFATjE4E9eJO-KGyNv0SrYfLg589NZPPvrACWdy0f3cZri5W20SHc8cHxZPa0Aeffq2AQ25-SvvPCFdsiYflsHN-II9681I-PLx3rMv728_33zI7j_dfbw53GdWtWXMsK6OlQEjqkrVpimVaqzsQYqiEqYA1VvbQdnXBVRdAXXTgTLCtn19LHsspVB79mabuwT_bUWKenJkcRzNjH4lLRpVy7Yuofm_VIlLmU3aYs-KTWqDJwrY6yW4yYSzFqAv1PRJb9T0hZoGoRO1ZHv9mLAeJ-z-mv5gSoJ3mwBTJd8dBk3W4Zy6dQFt1J13_074DdibrMw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1319622885</pqid></control><display><type>article</type><title>Altered phosphorylation of GluA1 in the striatum is associated with locomotor sensitization induced by exposure to increasing doses of morphine</title><source>ScienceDirect Freedom Collection</source><creator>Ding, Xuekun ; Liang, Jing ; Zheng, Xigeng ; Bai, Yunjing ; Liu, Zhengkui ; Li, Yingying ; Xing, Xiaoli</creator><creatorcontrib>Ding, Xuekun ; Liang, Jing ; Zheng, Xigeng ; Bai, Yunjing ; Liu, Zhengkui ; Li, Yingying ; Xing, Xiaoli</creatorcontrib><description>Escalation of drug consumption is involved in the transition from drug use to addiction. Our previous study demonstrated that neuronal activation in ventral tegmental area (VTA) and substantia nigra (SN) was associated with behavioral sensitization induced by increasing doses of morphine. Here we sought to characterize the molecular mechanism underlying this behavioral sensitization. We compared mitogen-activated protein kinase (MAPK) signaling following pretreatment with either increasing doses or fixed doses of morphine before and after behavioral sensitization. We found phospho-MAPK markedly increased in ventral striatum and decreased in dorsal striatum after either pretreatment group, but no further change after sensitization induced by 10mg/kg morphine challenge. Furthermore, we also evaluated the level of phospho-glutamate receptor 1 at serine 845 (pSer845-GluA1) and 831 (pSer831-GluA1) sites in ventral striatum and dorsal striatum. The results showed a significant increase in pSer845-GluA1/GluA1 ratio in ventral striatum but not dorsal striatum after pretreatment with increasing doses of morphine but not after fixed-dose or saline pretreatment. Importantly, pSer845-GluA1/GluA1 ratio was increased exclusively in dorsal striatum and not ventral striatum following acute morphine challenge specifically paired with increasing-dose pretreatment and not fixed-dose or saline. These findings indicate that behavioral sensitization-induced by chronic pretreatment with increasing doses of morphine might be more closely associated with the dynamic GluA1 activity in the striatum rather than the modulation of MAPK signaling. These findings also indicate that GluA1 phosphorylation may occur independent of MAPK activation.</description><identifier>ISSN: 0014-2999</identifier><identifier>EISSN: 1879-0712</identifier><identifier>DOI: 10.1016/j.ejphar.2013.01.051</identifier><identifier>PMID: 23396226</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Analgesics, Opioid - administration & dosage ; Animals ; Behavior, Animal - drug effects ; Corpus Striatum - drug effects ; Corpus Striatum - metabolism ; GluA1 ; Increasing doses ; Male ; MAPK signaling ; Mitogen-Activated Protein Kinases - metabolism ; Morphine ; Morphine - administration & dosage ; Motor Activity - drug effects ; Phosphorylation ; Rats ; Rats, Sprague-Dawley ; Receptors, AMPA - metabolism ; Striatum</subject><ispartof>European journal of pharmacology, 2013-02, Vol.702 (1-3), p.294-301</ispartof><rights>2013 Elsevier B.V.</rights><rights>Copyright © 2013 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c395t-e76b6a0a16637a85338c2f021461a403fccd05f7406d4078d03a1c9f7b5fe5213</citedby><cites>FETCH-LOGICAL-c395t-e76b6a0a16637a85338c2f021461a403fccd05f7406d4078d03a1c9f7b5fe5213</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23396226$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ding, Xuekun</creatorcontrib><creatorcontrib>Liang, Jing</creatorcontrib><creatorcontrib>Zheng, Xigeng</creatorcontrib><creatorcontrib>Bai, Yunjing</creatorcontrib><creatorcontrib>Liu, Zhengkui</creatorcontrib><creatorcontrib>Li, Yingying</creatorcontrib><creatorcontrib>Xing, Xiaoli</creatorcontrib><title>Altered phosphorylation of GluA1 in the striatum is associated with locomotor sensitization induced by exposure to increasing doses of morphine</title><title>European journal of pharmacology</title><addtitle>Eur J Pharmacol</addtitle><description>Escalation of drug consumption is involved in the transition from drug use to addiction. Our previous study demonstrated that neuronal activation in ventral tegmental area (VTA) and substantia nigra (SN) was associated with behavioral sensitization induced by increasing doses of morphine. Here we sought to characterize the molecular mechanism underlying this behavioral sensitization. We compared mitogen-activated protein kinase (MAPK) signaling following pretreatment with either increasing doses or fixed doses of morphine before and after behavioral sensitization. We found phospho-MAPK markedly increased in ventral striatum and decreased in dorsal striatum after either pretreatment group, but no further change after sensitization induced by 10mg/kg morphine challenge. Furthermore, we also evaluated the level of phospho-glutamate receptor 1 at serine 845 (pSer845-GluA1) and 831 (pSer831-GluA1) sites in ventral striatum and dorsal striatum. The results showed a significant increase in pSer845-GluA1/GluA1 ratio in ventral striatum but not dorsal striatum after pretreatment with increasing doses of morphine but not after fixed-dose or saline pretreatment. Importantly, pSer845-GluA1/GluA1 ratio was increased exclusively in dorsal striatum and not ventral striatum following acute morphine challenge specifically paired with increasing-dose pretreatment and not fixed-dose or saline. These findings indicate that behavioral sensitization-induced by chronic pretreatment with increasing doses of morphine might be more closely associated with the dynamic GluA1 activity in the striatum rather than the modulation of MAPK signaling. These findings also indicate that GluA1 phosphorylation may occur independent of MAPK activation.</description><subject>Analgesics, Opioid - administration & dosage</subject><subject>Animals</subject><subject>Behavior, Animal - drug effects</subject><subject>Corpus Striatum - drug effects</subject><subject>Corpus Striatum - metabolism</subject><subject>GluA1</subject><subject>Increasing doses</subject><subject>Male</subject><subject>MAPK signaling</subject><subject>Mitogen-Activated Protein Kinases - metabolism</subject><subject>Morphine</subject><subject>Morphine - administration & dosage</subject><subject>Motor Activity - drug effects</subject><subject>Phosphorylation</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Receptors, AMPA - metabolism</subject><subject>Striatum</subject><issn>0014-2999</issn><issn>1879-0712</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNqFkc2O1DAQhC0EYmcH3gAhH7kktO38XpBGq2VBWokLnC2P0yEeJXFwO7DDS_DKeJSFIxwsy1ZVV6s-xl4JyAWI6u0px9MymJBLECoHkUMpnrCdaOo2g1rIp2wHIIpMtm17xa6JTgBQtrJ8zq6kUm0lZbVjvw5jxIAdXwZP6YTzaKLzM_c9vxvXg-Bu5nFATjE4E9eJO-KGyNv0SrYfLg589NZPPvrACWdy0f3cZri5W20SHc8cHxZPa0Aeffq2AQ25-SvvPCFdsiYflsHN-II9681I-PLx3rMv728_33zI7j_dfbw53GdWtWXMsK6OlQEjqkrVpimVaqzsQYqiEqYA1VvbQdnXBVRdAXXTgTLCtn19LHsspVB79mabuwT_bUWKenJkcRzNjH4lLRpVy7Yuofm_VIlLmU3aYs-KTWqDJwrY6yW4yYSzFqAv1PRJb9T0hZoGoRO1ZHv9mLAeJ-z-mv5gSoJ3mwBTJd8dBk3W4Zy6dQFt1J13_074DdibrMw</recordid><startdate>20130228</startdate><enddate>20130228</enddate><creator>Ding, Xuekun</creator><creator>Liang, Jing</creator><creator>Zheng, Xigeng</creator><creator>Bai, Yunjing</creator><creator>Liu, Zhengkui</creator><creator>Li, Yingying</creator><creator>Xing, Xiaoli</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>20130228</creationdate><title>Altered phosphorylation of GluA1 in the striatum is associated with locomotor sensitization induced by exposure to increasing doses of morphine</title><author>Ding, Xuekun ; Liang, Jing ; Zheng, Xigeng ; Bai, Yunjing ; Liu, Zhengkui ; Li, Yingying ; Xing, Xiaoli</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c395t-e76b6a0a16637a85338c2f021461a403fccd05f7406d4078d03a1c9f7b5fe5213</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Analgesics, Opioid - administration & dosage</topic><topic>Animals</topic><topic>Behavior, Animal - drug effects</topic><topic>Corpus Striatum - drug effects</topic><topic>Corpus Striatum - metabolism</topic><topic>GluA1</topic><topic>Increasing doses</topic><topic>Male</topic><topic>MAPK signaling</topic><topic>Mitogen-Activated Protein Kinases - metabolism</topic><topic>Morphine</topic><topic>Morphine - administration & dosage</topic><topic>Motor Activity - drug effects</topic><topic>Phosphorylation</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Receptors, AMPA - metabolism</topic><topic>Striatum</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ding, Xuekun</creatorcontrib><creatorcontrib>Liang, Jing</creatorcontrib><creatorcontrib>Zheng, Xigeng</creatorcontrib><creatorcontrib>Bai, Yunjing</creatorcontrib><creatorcontrib>Liu, Zhengkui</creatorcontrib><creatorcontrib>Li, Yingying</creatorcontrib><creatorcontrib>Xing, Xiaoli</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>European journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ding, Xuekun</au><au>Liang, Jing</au><au>Zheng, Xigeng</au><au>Bai, Yunjing</au><au>Liu, Zhengkui</au><au>Li, Yingying</au><au>Xing, Xiaoli</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Altered phosphorylation of GluA1 in the striatum is associated with locomotor sensitization induced by exposure to increasing doses of morphine</atitle><jtitle>European journal of pharmacology</jtitle><addtitle>Eur J Pharmacol</addtitle><date>2013-02-28</date><risdate>2013</risdate><volume>702</volume><issue>1-3</issue><spage>294</spage><epage>301</epage><pages>294-301</pages><issn>0014-2999</issn><eissn>1879-0712</eissn><abstract>Escalation of drug consumption is involved in the transition from drug use to addiction. Our previous study demonstrated that neuronal activation in ventral tegmental area (VTA) and substantia nigra (SN) was associated with behavioral sensitization induced by increasing doses of morphine. Here we sought to characterize the molecular mechanism underlying this behavioral sensitization. We compared mitogen-activated protein kinase (MAPK) signaling following pretreatment with either increasing doses or fixed doses of morphine before and after behavioral sensitization. We found phospho-MAPK markedly increased in ventral striatum and decreased in dorsal striatum after either pretreatment group, but no further change after sensitization induced by 10mg/kg morphine challenge. Furthermore, we also evaluated the level of phospho-glutamate receptor 1 at serine 845 (pSer845-GluA1) and 831 (pSer831-GluA1) sites in ventral striatum and dorsal striatum. The results showed a significant increase in pSer845-GluA1/GluA1 ratio in ventral striatum but not dorsal striatum after pretreatment with increasing doses of morphine but not after fixed-dose or saline pretreatment. Importantly, pSer845-GluA1/GluA1 ratio was increased exclusively in dorsal striatum and not ventral striatum following acute morphine challenge specifically paired with increasing-dose pretreatment and not fixed-dose or saline. These findings indicate that behavioral sensitization-induced by chronic pretreatment with increasing doses of morphine might be more closely associated with the dynamic GluA1 activity in the striatum rather than the modulation of MAPK signaling. These findings also indicate that GluA1 phosphorylation may occur independent of MAPK activation.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>23396226</pmid><doi>10.1016/j.ejphar.2013.01.051</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0014-2999 |
ispartof | European journal of pharmacology, 2013-02, Vol.702 (1-3), p.294-301 |
issn | 0014-2999 1879-0712 |
language | eng |
recordid | cdi_proquest_miscellaneous_1837297508 |
source | ScienceDirect Freedom Collection |
subjects | Analgesics, Opioid - administration & dosage Animals Behavior, Animal - drug effects Corpus Striatum - drug effects Corpus Striatum - metabolism GluA1 Increasing doses Male MAPK signaling Mitogen-Activated Protein Kinases - metabolism Morphine Morphine - administration & dosage Motor Activity - drug effects Phosphorylation Rats Rats, Sprague-Dawley Receptors, AMPA - metabolism Striatum |
title | Altered phosphorylation of GluA1 in the striatum is associated with locomotor sensitization induced by exposure to increasing doses of morphine |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T17%3A35%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Altered%20phosphorylation%20of%20GluA1%20in%20the%20striatum%20is%20associated%20with%20locomotor%20sensitization%20induced%20by%20exposure%20to%20increasing%20doses%20of%20morphine&rft.jtitle=European%20journal%20of%20pharmacology&rft.au=Ding,%20Xuekun&rft.date=2013-02-28&rft.volume=702&rft.issue=1-3&rft.spage=294&rft.epage=301&rft.pages=294-301&rft.issn=0014-2999&rft.eissn=1879-0712&rft_id=info:doi/10.1016/j.ejphar.2013.01.051&rft_dat=%3Cproquest_cross%3E1837297508%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c395t-e76b6a0a16637a85338c2f021461a403fccd05f7406d4078d03a1c9f7b5fe5213%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1319622885&rft_id=info:pmid/23396226&rfr_iscdi=true |